Rabies Antiserum Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	155 Pages	Coherent Market Insights	May, 2023	CMI18001193

Best Price Guarantee
Price	from $4,500
Length	155 Pages
Publisher	Coherent Market Insights
Published Date	May, 2023
SKU	CMI18001193

Rabies Antiserum Market, By Product Type (Human Rabies Immunoglobulin (HRIG), Equine Rabies Immunoglobulin (ERIG)), By Application (Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Rabies antiserum is used to protect people who have been exposed to a potentially rabid animal. Rabies is a serious, almost always fatal disease that spreads from the saliva (spit) of an infected animal through a bite or scratch to humans and other animals. It can be prevented by getting immediate medical care and immunization after the exposure. It is recommended that travelers to high risk areas have a pre-exposure rabies vaccine series and be prepared with post-exposure prophylaxis (PEP) in case they are bitten or scratched by an infected animal. There are two types of rabies immunoglobulin available; human rabies immunoglobulin (HRIG) and equine rabies immunoglobulin (ERIG). HRIG is preferable when it is available, but if it is not, ERIG will be effective in neutralizing the rabies virus.

Market Dynamics:

The need to prevent rabies and the rising incidence of dog bites are expected to support growth of the rabies antiserum market. Additionally, the growing awareness regarding rabies vaccinations is also expected to propel growth of the market. Moreover, technological advancements and changing consumer behavior are other major factors expected to drive growth of the market over the forecast period.

On the other hand, lack of awareness regarding the advanced technology is expected to restrict the market growth.

Key features of the study:

This report provides in-depth analysis of the global rabies antiserum market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global rabies antiserum market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd., Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, MassBiologics, Serum Institute of India Ltd., Green Cross Corp., Haffkine, Bio-Pharmaceutical Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG (China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., and Beijing Tiantan Biological Products Co. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global rabies antiserum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rabies antiserum market

Detailed Segmentation:

Global Rabies Antiserum Market, By Product Type

Human Rabies Immunoglobulin (HRIG)

Equine Rabies Immunoglobulin (ERIG)

Global Rabies Antiserum Market, By Application

Pre-Exposure Prophylaxis (PrEP)

Post-Exposure Prophylaxis (PEP)

Global Rabies Antiserum Market, By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Rabies Antiserum Market, By Geography

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Company Profiles

CSL Behring

Sanofi Pasteur

Grifols S.A.

Bharat Serum and Vaccines Ltd.

Novartis AG

Kedrion Biopharma Inc.

Biogenesis Bago SA

MassBiologics

Serum Institute of India Ltd.

Green Cross Corp.

Haffkine Bio-Pharmaceutical Corporation Ltd.

Shanghai Institute of Biological Products Co. Ltd.

CNBG (China National Biotec Group) Co. Ltd.

Harbin Pharmaceutical Group Co. Ltd.

Beijing Tiantan Biological Products Co. Ltd.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Application; Market Snapshot, By Distribution Channel; Market Snapshot, By Geography; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Rising incidence of dog bites; Growing awareness regarding rabies vaccinations; Restraints; Lack of awareness regarding advanced technologies; Opportunities; Supportive government initiatives; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Rabies Antiserum Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Rabies Antiserum Market , By Product Type, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Human Rabies Immunoglobulin (HRIG); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Equine Rabies Immunoglobulin (ERIG); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
6. Global Rabies Antiserum Market , By Application, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Pre-Exposure Prophylaxis (PrEP); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion); Post-Exposure Prophylaxis (PEP); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
7. Global Rabies Antiserum Market , By Distribution Channel, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Distribution Channel; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion); Distribution Channel; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
8. Global Rabies Antiserum Market , By Region, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2017 –2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn)
9. Competitive Landscape: CSL Behring; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Sanofi Pasteur; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Sanofi Pasteur; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Bharat Serum and Vaccines Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Novartis AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Kedrion Biopharma Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Biogenesis Bago SA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; MassBiologics; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Serum Institute of India Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Haffkine Bio-Pharmaceutical Corporation Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Shanghai Institute of Biological Products Co. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; CNBG (China National Biotec Group) Co. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; CNBG (China National Biotec Group) Co. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Beijing Tiantan Biological Products Co. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Analyst Views; 10. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Rabies Antiserum Market” - Global forecast to 2030